ANK-3 Antibody (Mouse mAb) [F22J23]

Application: Reactivity: Dog, Human, Mouse, Rabbit, Rat

Usage Information

Dilution
WB1:1000 IF1:200-1:500

Application
WB, IP, IF, ELISA

Reactivity
Dog, Human, Mouse, Rabbit, Rat

Source
Mouse Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
480 kDa

Datasheet & SDS

Biological Description

Specificity
ANK-3 Antibody (Mouse mAb) [F22J23] detects endogenous levels of total ANK-3 protein.

Clone
F22J23

Synonym(s)
ANK-3; ankyrin 3 (G); ankyrin 3, epithelial; ankyrin 3, node of Ranvier (ankyrin G); ankyrin G; ankyrin-G; brain-specific ankyrin-G; cytoskeletal protein; ANK-3; AnkG; Ankyrin-3; ANKYRIN-G; MRT37

Background
Ankyrin‑G, encoded by ANK-3, is a member of the ankyrin family of modular scaffold proteins that link selected integral membrane proteins to the spectrin–actin cytoskeleton, and it is highly enriched at axon initial segments and nodes of Ranvier where it organizes specialized excitable domains required for action potential initiation and propagation. The protein contains an N‑terminal membrane‑binding domain formed by multiple ankyrin repeats that recognize cytoplasmic motifs in ion channels and adhesion molecules, a central spectrin‑binding region that connects to βIV‑spectrin and the submembranous actin network, and a C‑terminal regulatory tail that is subject to phosphorylation and other modifications, creating a flexible scaffold that stabilizes large macromolecular complexes at defined axonal segments. At axon initial segments, ankyrin‑G is required for the clustering of voltage‑gated sodium channels such as Nav1.6 and Nav1.2 together with the adhesion molecules neurofascin‑186 and NrCAM; conditional loss of ankyrin‑G disperses these channels and adhesion proteins, eliminates the high-density sodium channel cluster, and abolishes normal action potential firing, demonstrating that ankyrin‑G is an essential organizer of AIS excitability rather than a passive tether. The assembly mechanisms of ankyrin‑G–dependent domains differ between AIS and nodes of Ranvier: AIS formation is intrinsically specified by the early accumulation of ankyrin‑G, which then recruits neurofascin‑186 via its intracellular tail and supports sodium channel clustering from the inside toward the membrane, whereas peripheral nervous system nodes are specified by Schwann‑cell cues that target neurofascin‑186 to nodal axolemma through its extracellular domain and subsequently recruit ankyrin‑G and sodium channels from the outside in, defining distinct inside‑out and outside‑in assembly pathways that both converge on ankyrin‑G as a central scaffold. Ankyrin‑G not only concentrates Nav channels but also directly regulates their gating; co‑expression of ankyrin‑G with Nav1.6 reduces persistent sodium current while ankyrin‑B does not, and chimera experiments show that the membrane‑binding domain of ankyrin‑G is critical for this effect, indicating that ankyrin‑G can adjust channel biophysical properties in addition to organizing their spatial distribution. At developing nodes of Ranvier, giant ankyrin‑G isoforms co‑cluster with neurofascin, NrCAM and Nav channels within discrete segments of the spectrin–actin network, delineating early nodal intermediates that mature into fully functional nodes, and this scaffolding arrangement also shapes a diffusion barrier that preserves axonal identity by restricting somatodendritic proteins from entering the axon. Ankyrin‑G is expressed as multiple tissue‑specific splice variants, including giant neuronal isoforms uniquely targeted to AIS and nodes, and shorter isoforms present at epithelial cell–cell junctions and intracellular membranes where they anchor adhesion complexes and potentially modulate polarized trafficking, expanding the relevance of ankyrin‑G beyond classical neuronal excitability into broader aspects of cell architecture. Genetic and functional data link ANK3/ankyrin‑G to neuropsychiatric conditions such as bipolar disorder and autism spectrum disorder, consistent with the central role of AIS structure and Nav channel clustering in shaping neuronal firing patterns and circuit integration, and ankyrin‑G’s established importance in excitable cell domains has also connected this scaffold to cardiac arrhythmia and sudden death when cytoskeletal signaling pathways are disrupted.

Background

Ankyrin‑G, encoded by ANK-3, is a member of the ankyrin family of modular scaffold proteins that link selected integral membrane proteins to the spectrin–actin cytoskeleton, and it is highly enriched at axon initial segments and nodes of Ranvier where it organizes specialized excitable domains required for action potential initiation and propagation. The protein contains an N‑terminal membrane‑binding domain formed by multiple ankyrin repeats that recognize cytoplasmic motifs in ion channels and adhesion molecules, a central spectrin‑binding region that connects to βIV‑spectrin and the submembranous actin network, and a C‑terminal regulatory tail that is subject to phosphorylation and other modifications, creating a flexible scaffold that stabilizes large macromolecular complexes at defined axonal segments. At axon initial segments, ankyrin‑G is required for the clustering of voltage‑gated sodium channels such as Nav1.6 and Nav1.2 together with the adhesion molecules neurofascin‑186 and NrCAM; conditional loss of ankyrin‑G disperses these channels and adhesion proteins, eliminates the high-density sodium channel cluster, and abolishes normal action potential firing, demonstrating that ankyrin‑G is an essential organizer of AIS excitability rather than a passive tether. The assembly mechanisms of ankyrin‑G–dependent domains differ between AIS and nodes of Ranvier: AIS formation is intrinsically specified by the early accumulation of ankyrin‑G, which then recruits neurofascin‑186 via its intracellular tail and supports sodium channel clustering from the inside toward the membrane, whereas peripheral nervous system nodes are specified by Schwann‑cell cues that target neurofascin‑186 to nodal axolemma through its extracellular domain and subsequently recruit ankyrin‑G and sodium channels from the outside in, defining distinct inside‑out and outside‑in assembly pathways that both converge on ankyrin‑G as a central scaffold. Ankyrin‑G not only concentrates Nav channels but also directly regulates their gating; co‑expression of ankyrin‑G with Nav1.6 reduces persistent sodium current while ankyrin‑B does not, and chimera experiments show that the membrane‑binding domain of ankyrin‑G is critical for this effect, indicating that ankyrin‑G can adjust channel biophysical properties in addition to organizing their spatial distribution. At developing nodes of Ranvier, giant ankyrin‑G isoforms co‑cluster with neurofascin, NrCAM and Nav channels within discrete segments of the spectrin–actin network, delineating early nodal intermediates that mature into fully functional nodes, and this scaffolding arrangement also shapes a diffusion barrier that preserves axonal identity by restricting somatodendritic proteins from entering the axon. Ankyrin‑G is expressed as multiple tissue‑specific splice variants, including giant neuronal isoforms uniquely targeted to AIS and nodes, and shorter isoforms present at epithelial cell–cell junctions and intracellular membranes where they anchor adhesion complexes and potentially modulate polarized trafficking, expanding the relevance of ankyrin‑G beyond classical neuronal excitability into broader aspects of cell architecture. Genetic and functional data link ANK3/ankyrin‑G to neuropsychiatric conditions such as bipolar disorder and autism spectrum disorder, consistent with the central role of AIS structure and Nav channel clustering in shaping neuronal firing patterns and circuit integration, and ankyrin‑G’s established importance in excitable cell domains has also connected this scaffold to cardiac arrhythmia and sudden death when cytoskeletal signaling pathways are disrupted.

References
https://pubmed.ncbi.nlm.nih.gov/9832557/ https://pubmed.ncbi.nlm.nih.gov/17548513/

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%